Structure Therapeutics Inc - ADR

XNAS:GPCR 3:58:48 PM EDT

35.13

-0.37 (-1.04%)

3:59:56 PM EDT: $35.11 -0.02 (-0.06%)

Market Cap (Intraday)	2.51B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$50 Million
Adjusted EPS	-$0.33

See more estimates

10-Day MA	$39.76
50-Day MA	$48.31
200-Day MA	$54.51

See more pivots

Structure Therapeutics Inc - ADR Stock, XNAS:GPCR

601 Gateway Boulevard, Suite 900, South San Francisco, California 94080

United States of America

Phone: +1.650.457.1978

Number of Employees: 163

http://www.structuretx.com

Description

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. The company was founded by Raymond Stevens in February 2019 and is headquartered in South San Francisco, CA.